PACS and RIS Market

Market Restraints

High Implementation Cost

One of the major restraints hindering the growth of the PACS and RIS market is the high implementation cost associated with these systems. The upfront expenses related to purchasing, installing, and maintaining PACS and RIS systems can be significant, especially for smaller healthcare facilities such as community hospitals, outpatient clinics, and imaging centers. These costs can be prohibitively high, limiting the ability of these smaller institutions to adopt the technology.

In addition to the hardware and software costs, healthcare organizations must also account for expenses related to training staff, ensuring proper system integration, and maintaining ongoing updates, software upgrades, and robust data security measures. Staff training alone can incur substantial costs, as personnel need to become proficient in operating the new systems. Furthermore, integrating PACS and RIS with existing IT infrastructure in hospitals and clinics adds complexity and further increases costs. The effort and time required for a smooth integration process can make the overall investment even more challenging for smaller providers who already operate with tight budgets.

• For example, while the cost of PACS software for a practice generating 1,000 studies per month may be under US$ 10,000, the total cost of ownership can quickly rise to around US$ 40,000 when considering all associated expenses.

This high total cost of ownership can discourage smaller healthcare providers from adopting these systems, thus slowing the overall adoption rate and limiting the market’s growth potential. The need for significant financial investment is a barrier that many healthcare organizations, particularly in developing regions, find difficult to overcome, hindering the widespread use of PACS and RIS.

Market Opportunities

Favorable Government Policies and Funding

Favorable government funding have opened up significant new growth opportunities for the PACS and RIS market. Governments worldwide are increasingly recognizing the importance of digital health solutions, including imaging technologies, in improving healthcare delivery and reducing costs. As a result, they are introducing policies and allocating funding to support the adoption of advanced medical technologies such as PACS and RIS. These efforts not only encourage healthcare institutions to upgrade their systems but also stimulate innovation within the sector.

A notable example is INOVAIT, a pan-Canadian innovation network that supports advancements in image-guided therapy (IGT) and artificial intelligence (AI).

• In September 2024, INOVAIT announced the latest recipients of its Pilot Fund, which awards competitive funding to promising medical technology projects. This funding, totaling just under US$ 730,000, is directed toward initiatives that leverage AI, machine learning, and big data analytics to enhance medical imaging and streamline patient care.

The support fosters collaborations between small- and medium-sized enterprises, hospital research centers, and academic institutions, helping to drive innovation and job creation within the healthcare sector.

Such government-backed funding programs are crucial in accelerating the development and commercialization of cutting-edge imaging technologies. They provide the necessary resources for research, product development, and the integration of new technologies into healthcare systems. With continued government support, the PACS and RIS markets are expected to grow significantly, as these policies help to drive the adoption of digital imaging solutions and further transform healthcare delivery.

​Favorable government policies have significantly contributed to the growth of the PACS and RIS market.

• In the Union Budget for 2024-25, the Indian government introduced measures aimed at bolstering the domestic manufacturing of medical devices, which directly impact the affordability and accessibility of imaging technologies. One notable initiative is the provision of a 20% capital subsidy to companies investing in the production of components essential for digital X-ray, CT scan, and MRI machines.

Impact of macroeconomic factors / Geopolitical factors

The picture archiving and communication system and radiology information system markets are influenced significantly by broader macroeconomic and geopolitical factors, which affect investment levels, healthcare infrastructure development, supply chain continuity, and technology adoption worldwide.

One of the key macroeconomic factors is economic slowdown or inflation, which impacts healthcare budgets and capital expenditure, especially in developing regions. When national economies experience instability or currency devaluation, hospitals and imaging centers may delay or scale back purchases of PACS/RIS systems due to high initial investment and operational costs. Similarly, interest rate hikes can make financing large-scale IT infrastructure projects more challenging for public and private providers.

Geopolitical tensions, such as conflicts or strained international relations, can disrupt the global supply chain of medical imaging components and IT hardware required for PACS and RIS. For instance, instability in key supplier regions or sanctions on major technology exporters may lead to delays in product availability and higher input costs, affecting system deployment timelines and increasing operational expenses.

A specific geopolitical-economic factor affecting the PACS and RIS market is the United States’ tariff policies on imported technology goods, particularly from countries such as China. U.S. tariffs imposed on medical imaging components, servers, and electronic hardware have increased costs for vendors sourcing internationally. These cost hikes are often passed on to healthcare providers, making it more expensive to acquire or upgrade PACS and RIS systems.

The Trump administration announced plans to impose a 10% universal tariff on goods from all countries starting April 5, 2025. Additionally, government officials intend to implement further reciprocal tariffs on nations with which the U.S. has significant trade deficits, according to the American Hospital Association. AdvaMed, which represents over 50 imaging manufacturers, including Bayer, Canon, GE HealthCare, Philips, Siemens Healthineers, and others, criticized the move. The medical technology association has called for radiological devices to be exempt from tariffs, expressing concerns that these tariffs will drive up prices while limiting patient access to essential healthcare services.

Latest Trends

The global picture archiving and communication system and radiology information system markets are experiencing significant transformation driven by several key trends. Foremost among these is the integration of artificial intelligence (AI) into radiology workflows, enhancing diagnostic accuracy and streamlining image analysis. AI-powered PACS and RIS solutions are increasingly employed to automate routine tasks, reduce radiologist workload, and improve patient outcomes.

Additionally, the shift toward cloud-based deployments is gaining momentum, offering scalable, cost-effective, and accessible solutions, particularly beneficial for smaller healthcare facilities and those in remote locations. The adoption of vendor-neutral archives (VNAs) is also on the rise, facilitating interoperability among diverse imaging systems and enabling seamless data sharing across departments and institutions.

Furthermore, the growing emphasis on cybersecurity is prompting vendors to implement robust security measures to protect sensitive patient data from potential breaches. Collectively, these trends are reshaping the PACS and RIS landscape, fostering innovation, and driving the adoption of advanced imaging technologies worldwide.​

Regional Analysis

The Picture Archiving and Communication Systems (PACS) and Radiology Information Systems (RIS) markets in North America are experiencing significant growth, driven by technological advancements, increased healthcare digitization, and substantial investments in healthcare IT infrastructure.

The market is increasingly being shaped by the integration of Artificial Intelligence (AI) technologies. AI-powered tools within PACS systems, such as automated image analysis, lesion detection, and predictive analytics, are helping radiologists make faster, more accurate diagnoses. AI also aids in reducing repetitive manual tasks, freeing up radiologists’ time to focus on complex cases.

For example, AI can automatically prioritize images based on severity, helping to streamline workflows. This shift not only improves diagnostic accuracy but also enhances patient outcomes by enabling earlier intervention and personalized care. As a result, the demand for AI-enhanced PACS and RIS solutions is growing rapidly in North America.

• According to data from Healthcare Business International, updated in 2023, the US has nearly seven times the CT capacity per capita compared to Mexico, and almost 14 times the MRI capacity per capita.

Chronic diseases such as diabetes, cardiovascular conditions, and cancer are major contributors to the growing demand for advanced medical imaging systems in North America. These diseases require frequent monitoring, diagnostic imaging, and long-term care, placing significant pressure on healthcare systems to adopt efficient PACS and RIS solutions.

As the number of patients with chronic diseases rises, healthcare providers are increasingly relying on digital imaging technologies to detect, monitor, and manage these conditions. PACS and RIS platforms facilitate faster image retrieval, easier diagnosis, and the ability to track disease progression over time, which improves patient care and reduces the cost of long-term treatment. PACS systems are essential for storing and sharing large imaging files that are critical for cancer diagnosis and treatment planning.

• The Canadian Cancer Society reports that 2 in 5 Canadians are expected to be diagnosed with cancer during their lifetime.
• According to the American Cancer Society, the average risk of a woman in the US developing breast cancer at some point in her life is approximately 13%. The National Breast Cancer Foundation, Inc. estimates that in 2025, around 316,950 women and 2,800 men will be diagnosed with invasive breast cancer, alongside 59,080 new cases of non-invasive (in situ) breast cancer.

PACS and RIS Market, Region Analysis, 2020-2024 (US$ Million)